Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

5.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.1K
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

3.2K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
3.2K
The Thyroid Gland01:23

The Thyroid Gland

4.4K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
4.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GEF-H1 drives breast cancer cells to tumor progression.

Biochimica et biophysica acta. Molecular basis of disease·2025
Same author

Amorphous silica nanoparticles exhibit antitumor activity in triple-negative breast cancer cells.

Archiv der Pharmazie·2024
Same author

Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote Tumorigenesis.

Cancer immunology research·2024
Same author

Papillary Thyroid Carcinoma: A thorough Bioinformatic Analysis of Gene Expression and Clinical Data.

Genes·2023
Same author

Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability.

Antioxidants (Basel, Switzerland)·2022
Same author

Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development.

International journal of molecular sciences·2021

Related Experiment Video

Updated: Sep 13, 2025

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

1.8K

Heme-oxygenase-1: a key player in thyroid carcinoma development.

Exequiel Gonzalo Alonso1, Marilina Mascaró1, Karen Schweitzer1

  • 1Laboratorio de Biología del Cáncer, Instituto de Investigaciones Bioquímicas de Bahía Blanca (INIBIBB), Universidad Nacional del Sur (UNS)-CONICET, Dpto. de Biología, Bioquímica y Farmacia (UNS), Bahía Blanca, Argentina.

Endocrine-Related Cancer
|July 31, 2025
PubMed
Summary

Heme oxygenase-1 (HO-1) protein is elevated in papillary thyroid cancer and linked to progression. Overexpressing HO-1 promotes cancer cell growth and migration, suggesting it as a therapeutic target.

Keywords:
heme oxygenase-1nucleusthyroid cancertumor progression

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.5K
Measurement of Heme Synthesis Levels in Mammalian Cells
09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

12.2K

Related Experiment Videos

Last Updated: Sep 13, 2025

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

1.8K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.5K
Measurement of Heme Synthesis Levels in Mammalian Cells
09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

12.2K

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Thyroid cancer is a common endocrine malignancy, with papillary thyroid carcinoma being the most frequent subtype.
  • While papillary thyroid carcinoma is often curable, its progression to aggressive anaplastic thyroid cancer necessitates new therapeutic strategies.
  • Heme oxygenase-1 (HO-1) is a known biomarker for thyroid nodule malignancy, but its role in tumor progression and therapeutic potential is underexplored.

Purpose of the Study:

  • To investigate the role of HO-1 in thyroid cancer progression and its potential as a therapeutic target.
  • To determine the association between HO-1 expression levels and thyroid cancer malignancy and progression.
  • To elucidate the functional impact of HO-1 on thyroid cancer cell behavior and signaling pathways.

Main Methods:

  • Quantification of HO-1 protein in human papillary thyroid cancer tissues.
  • Correlation analysis of HO-1 mRNA levels with thyroid cancer progression.
  • Pharmacological and genetic manipulation of HO-1 expression in human papillary and anaplastic thyroid cancer cell lines.
  • Assessment of cell proliferation, migration, and cell cycle progression.
  • Investigation of MEK/ERK signaling pathway involvement.

Main Results:

  • HO-1 protein levels are increased in human papillary thyroid cancer tissues.
  • Elevated HO-1 mRNA expression correlates with progression to anaplastic thyroid cancer.
  • Overexpression of active HO-1 enhances proliferation, migration, and cell cycle progression in thyroid cancer cells.
  • The MEK/ERK signaling pathway is partially implicated in HO-1-mediated effects.

Conclusions:

  • HO-1 plays a significant protumorigenic role in thyroid cancer.
  • HO-1 may serve as a potential coadjuvant therapeutic target for both papillary and anaplastic thyroid cancer.
  • Targeting HO-1 could offer a novel strategy to combat thyroid cancer progression.